Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Skeleton-related event
2 years
No
Li Zhang, MD
Principal Investigator
Sun Yat-sen University
China: Food and Drug Administration
CZOL446ECN06T
NCT00762346
September 2008
August 2012
Name | Location |
---|